Irhythm Holdings Inc (IRTC) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Irhythm Holdings Inc   (NASDAQ: IRTC)

Select the Financial Report: Select the Period:


Description of Irhythm Holdings Inc's Business Segments


iRhythm Technologies Inc. is at the forefront of healthcare technology, particularly in the realm of cardiac care, focusing on the development of advanced monitoring solutions for patients experiencing cardiac arrhythmias. Established in 2006 and based in San Francisco, California, the company aims to enhance the identification, diagnosis, and management of heart conditions through innovative products and services.

Segments

iRhythm Technologies operates in two principal segments:

1. Diagnosis and Monitoring Services
2. Data and Analytics Services

1. Diagnosis and Monitoring Services

The cornerstone of iRhythms offerings is its wearable diagnostic monitoring technology. The flagship product, the ZioXT Patch, allows continuous heart rhythm monitoring.

- ZioXT Patch:
- This device can record a patient’s heart rhythm for up to two weeks, providing an extensive window for monitoring. It is designed to be small, lightweight, and water-resistant, which enables patients to carry on with their daily activities without interruption.
- The ZioXT Patch employs advanced algorithms to detect and characterize various cardiac arrhythmias, such as atrial fibrillation (AFib), bradycardia, and tachycardia. Its design allows it to be worn discreetly under clothing, making it a convenient option for patients.

This segment aims to empower cardiologists by providing them with concrete data that aids in diagnosing and monitoring patients afflicted with cardiac issues.

Data and Analytics Services

In tandem with its diagnostic devices, iRhythm Technologies delivers robust data and analytics services, which augment the effectiveness of its monitoring solutions.

- iRhythm Care Platform:
- This comprehensive platform aggregates the data collected from the ZioXT Patch, employing state-of-the-art artificial intelligence (AI) and machine learning algorithms for real-time analysis.
- The platform identifies abnormal heart rhythms and generates alerts for physicians, facilitating prompt responses to potential health issues.
- Additionally, the platform can integrate seamlessly with electronic health records (EHRs) and other clinical systems, offering a cohesive approach to patient data management.

Products

The primary products offered by iRhythm Technologies include:

1. ZioXT Patch
- A revolutionary device that monitors heart rhythm using sophisticated technology. It offers a two-week monitoring duration, waterproof design, and advanced detection capabilities.

2. iRhythm Care Platform
- A sophisticated analytics platform that processes and analyzes heart rhythm data from the ZioXT Patch. Its equipped to provide actionable insights to healthcare providers, enhancing diagnostic accuracy and patient management.

Services

iRhythm Technologies also offers a variety of services that support healthcare professionals, patients, and payers:

1. Diagnosis and Monitoring Services
- Through the ZioXT Patch, the company extends tools that allow for accurate diagnosis and ongoing monitoring of cardiac patients, sharing the responsibility of care with healthcare providers.

2. Data and Analytics Services
- With the iRhythm Care Platform, iRhythm empowers physicians by transforming complex data into understandable insights, thus streamlining the decision-making process in patient treatment plans.

3. Patient and Payer Support Services
- iRhythm provides extensive support for both patients and payers, aimed at enhancing outcomes and managing healthcare costs. Services may include patient education, personalized guidance on monitoring, and assistance with reimbursement processes to facilitate access to healthcare resources.

Conclusion

iRhythm Technologies Inc. stands as a pivotal player in the healthcare landscape, particularly within cardiac care. The companys innovative products and services are not only designed to enhance patient outcomes but also to reduce costs and improve overall efficiency in the diagnosis and management of cardiac arrhythmias. Through the integration of advanced monitoring technology and cutting-edge analytics, iRhythm is redefining the approach to cardiac health, paving the way for improved healthcare delivery and patient experiences.


Composition of Irhythm Holdings Inc Revenues by Segments

 
Contracted third-party payors    53.58 % of total Revenue
Centers for Medicare Medicaid Services    25.78 % of total Revenue
Healthcare institutions    15.13 % of total Revenue
Non-contracted third-party payors    5.54 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Contracted third-party payors 106.80 53.58 %
Centers for Medicare Medicaid Services 51.39 25.78 %
Healthcare institutions 30.15 15.13 %
Non-contracted third-party payors 11.04 5.54 %
Total 199.35 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Contracted third-party payors 27.45 % -
Centers for Medicare Medicaid Services 34.84 % -
Healthcare institutions 13.05 % -
Non-contracted third-party payors 9.44 % -
Total 26 % -73.29 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -13.93 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Irhythm Holdings Inc Divisions, Sales by Country

 
Contracted third-party payors   Contracted third-party payors Segment contribution to total sales 52.56 % of total Revenue
Healthcare institutions   Healthcare institutions Segment contribution to total sales 16.83 % of total Revenue
Non-contracted third-party payors   Non-contracted third-party payors Segment contribution to total sales 6.69 % of total Revenue
Centers for Medicare and Medicaid   Centers for Medicare and Medicaid Segment contribution to total sales 24.03 % of total Revenue


Twelve months ended 2025
IRTC s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Contracted third-party payors 392.23 52.56 %
Healthcare institutions 125.61 16.83 %
Non-contracted third-party payors 49.94 6.69 %
Total 746.25 100 %
Centers for Medicare and Medicaid 179.35 24.03 %


Twelve months ended 2025
IRTC s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -44.55 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Contracted third-party payors 25.88 % -
Healthcare institutions 32.06 % -
Non-contracted third-party payors 16.88 % -
Total 26.16 % -
Centers for Medicare and Medicaid 25.96 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.